Cubist Systematic Strategies, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 158 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$264,966
-61.0%
82,544
-61.5%
0.00%
-60.0%
Q3 2023$678,836
+586.3%
214,144
+975.9%
0.01%
+400.0%
Q2 2023$98,918
-95.8%
19,903
-95.8%
0.00%
-92.9%
Q1 2023$2,334,851
+28.4%
472,642
+63.5%
0.01%
+27.3%
Q4 2022$1,817,804
-70.9%
288,999
-50.1%
0.01%
-68.6%
Q3 2022$6,256,000
+99.7%
579,245
+110.8%
0.04%
+84.2%
Q2 2022$3,133,000
+66.9%
274,800
+33.4%
0.02%
+18.8%
Q1 2022$1,877,000
-10.7%
206,033
+46.3%
0.02%
-20.0%
Q4 2021$2,101,000
-35.4%
140,790
+13.0%
0.02%
-45.9%
Q2 2021$3,250,000
+227.6%
124,598
+343.4%
0.04%
+184.6%
Q1 2021$992,000
-65.0%
28,101
-75.0%
0.01%
-66.7%
Q4 2020$2,835,000
+454.8%
112,321
+840.5%
0.04%
+333.3%
Q2 2020$511,000
+87.9%
11,943
-14.8%
0.01%
+28.6%
Q1 2020$272,000
-73.0%
14,012
-63.9%
0.01%
-61.1%
Q4 2019$1,009,00038,8330.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$4,189,7204.58%
SUPERSTRING CAPITAL MANAGEMENT LP 689,912$1,607,4952.03%
Lynx1 Capital Management LP 2,228,295$5,191,9271.87%
Wildcat Capital Management, LLC 2,920,787$6,805,4341.66%
TPG GP A, LLC 18,716,306$43,608,9931.00%
Boxer Capital, LLC 3,850,000$8,970,5000.47%
Vestal Point Capital, LP 2,200,000$5,126,0000.38%
DAFNA Capital Management LLC 605,100$1,409,8830.34%
Frazier Life Sciences Management, L.P. 2,867,750$6,681,8580.31%
Coastal Bridge Advisors, LLC 406,847$947,9540.24%
View complete list of ALLOGENE THERAPEUTICS INC shareholders